Lv1
100 积分 2025-04-22 加入
Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancer
8个月前
已完结
Survival with Cemiplimab in Recurrent Cervical Cancer
8个月前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
8个月前
已完结
寡转移性宫颈癌的立体定向放疗（MITO-RT2/RAD 研究）：MITO、AIRO GYN 和 MaNGO 小组的合作
9个月前
已完结
皖公网安备34019202002308
